Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

The Pharmaceutical Journal

Editorial

Patients taking medicines affected by new drug driving laws will need timely and accurate advice from pharmacists

Drug driving law must not be a burden for patients

Patients taking medicines affected by new drug driving laws will need timely and accurate advice from pharmacists.

No-blame culture should be fostered in pharmacySubscription

Even though the requirement to name a community pharmacy in patient safety reports has been postponed, the sector must do more to improve the reporting of dispensing errors.

Feature

Unlike the United States, Europe has no plan for coordinated action to mitigate drug shortages

Drug shortages: it’s time for Europe to act Subscription

By

Unlike the United States, Europe has no plan for coordinated action to mitigate drug shortages.

Comment

According to suggestions from the latest Nuffield Trust report "Now more than ever" community pharmacists must shift their core activities away from dispensing function towards a more clinical role

Dispensing: it’s time to let it goSubscription

By

If the aspirations of pharmacy fulfilling a clinical role integral to public healthcare is ever to be realised, community pharmacists must shift their focus away from dispensing and towards providing health services.

CPD article

Light micrograph of liver sarcoidosis, a non-malignant immunological disorder characterised by non-caseating (non-necrotising) granulomas.

Identifying and managing sarcoidosisSubscription

By ,

Sarcoidosis is a complex immunological disorder that requires careful management and vigilant monitoring.

Careers

Amira Guirguis, a researcher, is designing a model to improve on-site identification of new psychoactive substances of misuse

Discovering how to identify new psychoactive substances through PhD researchSubscription

By Amira Guirguis

Researcher Amira Guirguis is designing a model to improve on-site identification of new psychoactive substances of misuse. She explains why the work is vital to reduce unnecessary hospital admissions and prevent avoidable deaths.

News

The Human Protein Atlas shows the locations of almost 17,000 different proteins in the human body could offer invaluable guidance for drug developers

Human Protein Atlas reveals drug targetsSubscription

The Human Protein Atlas shows the locations of almost 17,000 different proteins in the human body and could offer invaluable guidance for drug developers. 

The European Medicines Agency (EMA) approved AbbVie’s Viekirax and Exviera, licensed together for the treatment of hepatitis C genotype 1

EU approval of AbbVie’s hepatitis C combination therapies challenges Gilead’s HarvoniSubscription

A highly effective therapy for patients with hepatitis C is being launched by AbbVie in the EU over the next couple of months in direct competition with another treatment made by Gilead that was approved in 2014 and is now being rolled out. 

The Pharmaceutical Journal

31 January 2015, Vol 294, No 7847

Cover Story:

Drug shortages across Europe are hitting patients hard, prompting regulators, drug manufactures and patient groups to call for an overhaul of the system monitoring medicines supply.

Read more…

The Pharmaceutical Journal

View previous issue

YOUR RPS

Alex MacKinnon, director, Royal Pharmaceutical Society (RPS) for Scotland

RPS Scotland targets greater clinical role for pharmacy in 2015Subscription

By

Business plan for 2015 sets out Royal Pharmaceutical Society Scotland’s ambitions for the Prescription for Excellence programme

Notice-board

For latest notifications, opportunities and product updates, visit the notice-board page here.

Announcements

For official announcements from The Royal Pharmaceutical society please visit the announcements page here.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.